The Inflation Reduction Act (IRA) authorizes the Secretary of the Department of Health and Human Services (HHS) to negotiate prices directly with participating manufacturers for selected drugs that are high expenditure, single source drugs without generic or biosimilar competition.
Demographic Data
Reports
Displaying 11 - 20 of 67. 10 per page. Page 2.
Advanced SearchReport
Inflation Reduction Act Research Series: Medicare Part D Enrollee Out-of-Pocket Spending: Recent Trends and Projected Impacts of the Inflation Reduction Act
The Inflation Reduction Act (IRA) will make key changes to improve drug affordability for people who have Medicare.
ASPE Issue Brief
Updated National Survey Trends in Telehealth Utilization and Modality (2021-2022)
Telehealth utilization has changed over time since the steep increase from the early stages of the COVID-19 pandemic. This report updates prior findings on national trends of telehealth use through an analysis using the Census Bureau’s Household Pulse Survey data from April 2021 through August 2022.
ASPE Issue Brief
Medicaid Enrollees Who are Employed: Implications for Unwinding the Medicaid Continuous Enrollment Provision
Many Medicaid enrollees are employed, and in 2021, 15 percent of working enrollees reported having both Medicaid and employer sponsored health coverage. The intersection between Medicaid and employment has implications for employers and others as the pandemic-related Medicaid continuous enrollment ends.
ASPE Issue Brief
Inflation Reduction Act Research Series: Medicare Part D Enrollee Savings from Elimination of Vaccine Cost-Sharing
Effective January 1, 2023, the Inflation Reduction Act (IRA) eliminated enrollee cost-sharing for recommended vaccines covered under Medicare Part D. In 2021, 3.4 million people received vaccines under Part D, and annual out-of-pocket costs were $234 million.
ASPE Issue Brief
Unvaccinated for COVID-19 but Willing: Demographic Factors, Geographic Patterns, and Changes Over Time
As of August 4, 2021, 70.1 percent of U.S. adults have received at least one dose of a COVID-19 vaccine. However, vaccine coverage varies dramatically across the country, with vaccine coverage being less than 40 percent in a third of U.S. counties. Despite a sufficient supply of COVID-19 vaccines, daily vaccinations have dwindled in recent months.
Disparities in COVID-19 Vaccination Rates across Racial and Ethnic Minority Groups in the United States
Ensuring equitable distribution of the COVID-19 vaccine is essential to mitigate the disproportionate impact of COVID-19 on racial and ethnic minority populations. This brief summarizes currently available data on race and ethnicity of vaccinated persons at the state level.
Factors influencing variation between states in efficiency of COVID-19 vaccine administration
Limited initial supplies of the COVID-19 vaccine necessitated the development of strategies to ensure efficient and equitable vaccine distribution. This brief summarizes the different vaccine distribution strategies and approaches taken by states and evaluates the extent to which these may have impacted the efficiency with which doses delivered to states are administered to patients.
ASPE Issue Brief
Age Group Differences in Progress toward Reducing Substance Use Disorders, 2015-2018 Issue Brief
Age Group Differences in Progress toward Reducing Substance Use Disorders, 2015-2018 ASPE ISSUE BRIEF Ellen Bouchery Mathematica March 2021 Link to Printer Friendly Version in PDF Format (7 PDF pages)
Health Disparities by Race and Ethnicity during the COVID-19 Pandemic: Current Evidence and Policy Approaches
The COVID-19 pandemic has highlighted stark health disparities among Black, Hispanic, Native American, and Native Hawaiian/Pacific Islander populations in several areas, including infections, hospitalizations, death rates, and vaccination rates.